State of the Medtech, Diagnostics & Digital Health landscape in Q2 2025
In this update, we explore the investment landscape across MedTech, Diagnostics, and Digital Health in Q2 2025. Deal activity centred on early‑stage tickets and significant growth‑round funding, with capital flowing into technologies addressing regulatory hurdles and chronic conditions. We also highlight several stand‑out growth rounds shaping Europe’s innovation scene.
